At
Funding Series
Series B
Funding Amount
¥15m
[data from INITIAL 2024 Dec]
Healthcare/Medtech Manufacturing

About

A deeptech startup from Osaka University in the healthcare a​nd pre‐symptomatic field, At visualizes pre‐symptomatic disease using a capillary scope.

Milestone

At will complete mass production of its autofocus capillary scope in 2025 to exhibit at the Osaka Kansai Expo. In 2026 they aim to establish a lifestyle-related disease risk assessment system, expanding with the goal of an IPO in 2028.
Visit Site
We're Here to Help
Have questions? Not sure where to start? Send us an email and let’s chat!
Email Us
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.